AJP - GI AJP: Heart and Circulatory Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Gastrointest Liver Physiol 280: G1360-G1369, 2001;
0193-1857/01 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (26)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Musallam, L.
Right arrow Articles by Bilodeau, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Musallam, L.
Right arrow Articles by Bilodeau, M.
Vol. 280, Issue 6, G1360-G1369, June 2001

Role of EGF receptor tyrosine kinase activity in antiapoptotic effect of EGF on mouse hepatocytes

Lina Musallam1,2, Chantal Éthier1, Pierre S. Haddad1,2, and Marc Bilodeau1

1 Centre de Recherche, Centre Hospitalier de l'Université de Montréal-Hôpital Saint-Luc, and 2 Department of Pharmacology, Université de Montréal, Montreal, Quebec, Canada H2X 1P1

The apoptotic Fas pathway is potentially involved in the pathogenesis of liver diseases. Growth factors, such as epidermal growth factor (EGF), can protect cells against apoptosis induced by a variety of stimuli, including Fas receptor stimulation. However, the underlying mechanisms of this protection have yet to be determined. We investigated the involvement of EGF receptor (EGFR) tyrosine kinase (TK) activity in the antiapoptotic effect of EGF on primary mouse hepatocyte cultures. Cells undergoing apoptosis after treatment with anti-Fas antibody were protected by EGF treatment. This protection was significantly but partially decreased when cells were treated with two specific inhibitors of the TK activity of EGFR. Evaluation of the efficacy of these compounds indicated that they were able to abolish EGFR autophosphorylation and postreceptor events such as activation of mitogen-activated protein kinases and the phosphatidylinositol 3'-kinase pathways as well as increases in Bcl-xL mRNA and protein levels. This leads us to postulate that EGF exerts its antiapoptotic action partially through the TK activity of EGFR. In addition, our results suggest that Bcl-xL protein upregulation caused by EGF is linked to the TK activity of its receptor.

apoptosis; Fas; Bcl-xL; receptor autophosphorylation; inhibitors of receptor tyrosine kinases


This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
K. Takeda, Y. Kojima, K. Ikejima, K. Harada, S. Yamashina, K. Okumura, T. Aoyama, S. Frese, H. Ikeda, N. M. Haynes, et al.
Death receptor 5 mediated-apoptosis contributes to cholestatic liver disease
PNAS, August 5, 2008; 105(31): 10895 - 10900.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
W.-Z. Ying, H.-G. Zhang, and P. W. Sanders
EGF Receptor Activity Modulates Apoptosis Induced by Inhibition of the Proteasome of Vascular Smooth Muscle Cells
J. Am. Soc. Nephrol., January 1, 2007; 18(1): 131 - 142.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M. Y. Lee, S. H. Park, Y. J. Lee, J. S. Heo, J. H. Lee, and H. J. Han
EGF-induced inhibition of glucose transport is mediated by PKC and MAPK signal pathways in primary cultured chicken hepatocytes
Am J Physiol Gastrointest Liver Physiol, October 1, 2006; 291(4): G744 - G750.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M. Constante, W. Jiang, D. Wang, V.-A. Raymond, M. Bilodeau, and M. M. Santos
Distinct requirements for Hfe in basal and induced hepcidin levels in iron overload and inflammation
Am J Physiol Gastrointest Liver Physiol, August 1, 2006; 291(2): G229 - G237.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
C. Ethier, V.-A. Raymond, L. Musallam, R. Houle, and M. Bilodeau
Antiapoptotic effect of EGF on mouse hepatocytes associated with downregulation of proapoptotic Bid protein
Am J Physiol Gastrointest Liver Physiol, July 7, 2003; 285(2): G298 - G308.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
R. Prochazka, P. Kalab, and E. Nagyova
Epidermal Growth Factor-Receptor Tyrosine Kinase Activity Regulates Expansion of Porcine Oocyte-Cumulus Cell Complexes In Vitro
Biol Reprod, March 1, 2003; 68(3): 797 - 803.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
L. Musallam, C. Ethier, P. S. Haddad, F. Denizeau, and M. Bilodeau
Resistance to Fas-induced apoptosis in hepatocytes: role of GSH depletion by cell isolation and culture
Am J Physiol Gastrointest Liver Physiol, September 1, 2002; 283(3): G709 - G718.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. R. Wedge, D. J. Ogilvie, M. Dukes, J. Kendrew, R. Chester, J. A. Jackson, S. J. Boffey, P. J. Valentine, J. O. Curwen, H. L. Musgrove, et al.
ZD6474 Inhibits Vascular Endothelial Growth Factor Signaling, Angiogenesis, and Tumor Growth following Oral Administration
Cancer Res., August 15, 2002; 62(16): 4645 - 4655.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online